Luigi Mangione, accused of fatally shooting UnitedHealthcare CEO Brian Thompson in December 2024, is expected to change his plea to guilty in federal court on Friday. The decision marks a significant shift from his previous not-guilty plea to federal charges of stalking resulting in death.
David Gelman, a former prosecutor who now runs a criminal defense firm, suggested that the plea change could be a strategic move by Mangione's legal team to avoid a life sentence. "If I were his attorney, I think it would probably be the best situation for him," Gelman stated, noting that Mangione faces a potential maximum sentence of life in prison without parole.
The federal trial was initially scheduled to begin in January. If Mangione pleads guilty, his lawyers are expected to argue that state murder charges, with a trial set to start next month, should be dismissed based on double jeopardy principles under New York law. The prosecution is anticipated to contest this, arguing that the state murder charges are distinct from the federal stalking charges.
This legal maneuver could derail the state's case, with the ultimate decision resting with the state court judge. Gelman described the competition between federal and state prosecutors to bring Mangione to trial as "unusual," attributing it to the case's high profile and the significant resources invested in apprehending him.
Mangione was apprehended in Altoona, Pennsylvania, after being on the run for five days following the shooting in Midtown Manhattan. The arrest occurred after a McDonald's manager reported a man matching his description.
If the state case proceeds, Mangione's defense might attempt to select a jury that is younger and potentially sympathetic to his actions, given his "cult following" and a defense fund reportedly supported by younger donors. Gelman suggested this strategy would aim to find jurors who might "hate the healthcare industry" and "almost want to justify his actions."
Earlier in the week, Mangione's lawyers withdrew a planned defense of "extreme emotional disturbance." Gelman indicated this decision was likely based on expert analyses suggesting the defense would not be effective and could be detrimental under cross-examination. The attorneys are now placing their hopes on the anticipated guilty plea to navigate the legal complexities and potentially secure a less severe sentence.
